| Financial Year |
September 30 2019 |
| Monetary Funds |
163,041,406.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
32,675,879.70 |
| Accounts Receivable |
3,220,336,673.55 |
| Advances to Suppliers |
405,001,356.83 |
| Other Receivables |
1,563,100,659.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,024,174,957.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,975,630.09 |
| Total Current Assets |
6,517,382,354.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
16,708,613.19 |
| Long-term Equity Investment |
106,837,810.83 |
| Investment Properties |
-- |
| Fixed Assetes |
136,058,418.88 |
| Under-construction Projects |
36,805,894.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,281,588.93 |
| R&D expenses |
-- |
| Goodwill |
27,268,234.53 |
| Long-Term Deferred and Prepaid Expenses |
1,972,106.61 |
| Deferred Income Tax Assets |
117,317,681.38 |
| Other Non-Current Assets |
919,731,651.85 |
| Sub-Total of Non-Current Assets |
1,452,982,000.23 |
| Total Assets |
7,970,364,354.91 |
| Short-Term Loans |
3,306,944,094.49 |
| Trading Financial liabilities |
-- |
| Notes Payable |
396,643,774.40 |
| Accounts Payable |
795,538,450.44 |
| Accounts Received In Advance |
552,109,041.13 |
| Employee Compensation Payable |
71,791,324.92 |
| Taxes Payable |
376,111,541.28 |
| Interest Payable |
629,925,428.55 |
| Dividend Payable |
8,392,335.45 |
| Other payables |
2,343,796,096.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
975,719,981.55 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
8,818,654,305.11 |
| Long-term Loans |
120,000,000.00 |
| Bonds Payable |
272,468,101.18 |
| Long-Term Accounts Payable |
270,267.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,958,723.15 |
| Deferred Income Tax Liabilities |
23,079,827.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
418,776,918.91 |
| Total Liabilities |
9,237,431,224.02 |
| Paid-In Capital(Or Share Stock) |
1,698,245,011.00 |
| Capital Surplus |
-1,298,846,540.07 |
| Surplus Reserve |
84,394,441.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,798,146,919.52 |
| Minority Stockholder's Interest |
30,349,787.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,297,416,656.35 |
| Owner's Equity（Stockholder's Equity） |
-1,267,066,869.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,970,364,354.91 |
